We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Hyperactive Cysteine Sites Identified by New Quantitative Reactivity Technique

By LabMedica International staff writers
Posted on 14 Dec 2010
Print article
A publication described a new method for determining active regions on enzymes and other proteins by using specific probes in a fashion that discriminated between high and low affinity amino acid sites.

Investigators at the Scripps Research Institute (La Jolla, CA, USA) initially used the new technology to study the reactivity of cysteine residues in enzymes. Cysteine is one of the most reactive of the amino acids and is often critically involved in determining the three-dimensional shape of protein molecules.

Two types of cysteine-specific probes were used. One probe bound to cysteine with high affinity while the other was less avid. This meant that by strictly controlling the concentration of the probe, they could determine whether it was binding to a particularly active or inactive cysteine site.

The investigators reported in the November 17, 2010, online edition of the journal Nature that they tested the technique on proteins found within a human breast cancer-cell line. They were able to identify and locate more than 800 cysteine sites on 522 proteins. For more than 90% percent of these cysteine sites the low and high concentration probes showed correspondingly low and high levels of labeling, indicating that the cysteine residues had ordinary reactivity. The other 10% of cysteine sites demonstrated a constant level of labeling for both low and high concentration probes, indicating that they were hyperreactive.

"What we have needed is a more efficient method to find and quantitatively analyze reactive sites,” said senior author Dr. Benjamin F. Cravatt, professor of chemical biology and physiology at the Scripps Institute, "not just for one protein in a purified sample but for a large set of proteins in their natural setting, such as within a whole cell or tissue.”

"It lets us find functional sites on proteins more efficiently than before, and that is going to be helpful not only for characterizing unknown proteins, but also for finding new sites of importance on already-characterized proteins. This is a relatively precise and straightforward method for screening designed proteins for functional properties,” said Dr. Cravatt. "It could be very useful for creating new enzyme catalysts for basic research and industrial applications.”

Related Links:

Scripps Research Institute


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Quantitative Immunoassay Analyzer
AS050
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.